Khajanchee Y S, Streeter D, Swanstrom L L, Hansen P D
Department of Minimally Invasive Surgery, Legacy Health System, 1040 Northwest 22nd Avenue, Suite 560, Portland, OR 97210, USA.
Surg Endosc. 2004 Apr;18(4):696-701. doi: 10.1007/s00464-003-8180-3. Epub 2004 Mar 19.
Radiofrequency ablation (RFA) is rapidly evolving as an effective minimally invasive technique for the treatment of small and unresectable liver tumors. A potential cause of treatment failure is the inability to determine the optimum number of overlapping ablations needed to completely destroy tumors larger than the size of a single ablation. To clarify this relationship, we performed a mathematical evaluation that enables us to accurately estimate the number of ablations needed to completely ablate larger tumors.
This estimation is based on the assumptions that complete ablation of the surface of a target tumor, including its blood supply, would completely destroy the tumor and that the tumor and ablations produced are perfectly spherical. The smallest possible number of partially overlapping ablations that would completely cover the surface of the target tumor is the same as the number of faces on a regular polyhedron that has a circumscribing diameter equal to or greater than the diameter of the target sphere.
This mathematical analysis shows that for a 5-cm ablation device, tumors with diameters ranging between 3.01 and 3.30 cm will require at least four ablations. Tumors between 3.31 and 4.12 cm require six overlapping ablations, and tumors between 4.13 and 6.23 cm require 12 overlapping ablations. The number of ablations needed for larger tumors and for 3-, 4-, 6-, and 7-cm ablation devices are also determined.
The smallest number of ablations required to completely ablate a spherical target tumor larger than the size of the ablation sphere increases dramatically as tumor size increases. Because this model is geometrically optimized, even a small change in the position of the ablation spheres with respect to the target sphere can leave potentially unablated tumor and thus result in treatment failure.
射频消融术(RFA)作为一种治疗小的不可切除性肝肿瘤的有效微创技术正在迅速发展。治疗失败的一个潜在原因是无法确定完全摧毁大于单次消融范围的肿瘤所需的最佳重叠消融次数。为了阐明这种关系,我们进行了一项数学评估,使我们能够准确估计完全消融较大肿瘤所需的消融次数。
该估计基于以下假设:完全消融目标肿瘤表面,包括其血供,将完全摧毁肿瘤,并且产生的肿瘤和消融区域是完美球形。完全覆盖目标肿瘤表面所需的最小部分重叠消融次数与具有等于或大于目标球体直径的外接直径的正多面体的面数相同。
该数学分析表明,对于5厘米的消融设备,直径在3.01至3.30厘米之间的肿瘤至少需要4次消融。直径在3.31至4.12厘米之间的肿瘤需要6次重叠消融,直径在4.13至6.23厘米之间的肿瘤需要12次重叠消融。还确定了较大肿瘤以及3厘米、4厘米、6厘米和7厘米消融设备所需的消融次数。
完全消融大于消融球体大小的球形目标肿瘤所需的最小消融次数随着肿瘤大小的增加而急剧增加。由于该模型在几何上是优化的,消融球体相对于目标球体位置的微小变化都可能留下潜在未消融的肿瘤,从而导致治疗失败。